Trial Profile
Phase I trial of Tolerizing immonutherapy in patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2016
Price :
$35
*
At a glance
- Drugs DEN 181 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Dendright
- 06 Apr 2016 New trial record
- 04 Jun 2015 Status change from planning to completed, as per Dendright media release.